Monday, June 21, 2021
Home National Bharat Biotech to begin trial of Covaxin vaccine for age group 2...

Bharat Biotech to begin trial of Covaxin vaccine for age group 2 to 18

Hyderabad-based Bharat Biotech has been given permission to begin the second and third phase clinical trial to assess the safety and immunity of Covaxin on children aged two to 18 years. The trial will be conducted on 525 volunteers at various centers in the country, including AIIMS in Delhi and Patna and the Meditrina Institute of Medical Sciences in Nagpur. Bharat Biotech has developed Covaxin in collaboration with the Indian Council of Medical Research (ICMR). The company is also producing and marketing it. In India, Covaxin is being used along with Serum Institute of India’s Covishield in vaccination campaigns.

Read more: News 18 | The New Indian Express | Livemint

50% LikesVS
50% Dislikes

News Verification For Headline Auditors

If this seems like a news that is relevant to your industry. Would you like to verify the authenticity of the news?
Please Enter your Secret Key

We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.

Report Post

Shrutika Kasar
Shrutika Pradeep Kasar Journalist Writer music lover